Gufic Biosciences Limited (BSE: 509079)
Health Care · Pharmaceuticals · IN
Rs404.80
-3.20% today · +10.7% 1Y
Gufic Biosciences Limited (BSE: 509079) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $419.45M.
Over the last twelve months the share price has gained 10.7%, trading between 267.50 and 466.05.
Tweenvest scores Gufic Biosciences Limited across four factors: quality 69/100, value 38/100, growth 35/100, dividend 23/100. Its strongest factor is quality.
509079 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $419.45M
- Revenue (TTM)
- $103.76M
- P/E
- 55.28
- EPS
- 7.32
- Dividend yield
- 0.02%
- Beta (5Y)
- -0.03
- 52-week high
- Rs466.05
- 52-week low
- Rs267.50
- Avg volume (3M)
- —
- Shares outstanding
- 100.28M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| SMS Pharmaceuticals LimitedNSEI: SMSPHARMA | $430.28M | Rs444.65 | -5.65% |
| Anhui Fengyuan Pharmaceutical Co., Ltd.SZSE: 000153 | $427.35M | CN¥6.16 | +0.82% |
| Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim SirketiIBSE: GENIL | $425.91M | TL4.67 | -11.89% |
| Lumosa Therapeutics Co., Ltd.TPEX: 6535 | $425.85M | NT$81.30 | -4.35% |
| Renata PLCDSE: RENATA | $418.98M | Tk449.90 | +0.27% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,LtdSHSE: 600671 | $416.71M | CN¥22.92 | +5.19% |
| Chengdu huasun technology group Inc. , LTD.SZSE: 000790 | $413.45M | CN¥4.44 | +0.45% |
| Atea Pharmaceuticals, Inc.NasdaqGS: AVIR | $413.05M | $5.09 | -1.17% |
Figures last refreshed Oct 11, 2026.